LIVE FROM CPHI: Azelis agrees polyvinylpyrolidones (PVP) partnership with JH Nanhang

Published: 22-Oct-2013
Ingredients

For pharmaceutical applications across Europe, Russia, Turkey and North Africa


Speciality chemical distributor Azelis has fsigned an exclusive agreement with JH Nanhang (JHNH) to supply the Chinese company's range of polyvinylpyrolidones (PVP) for pharmaceutical applications across Europe, Turkey, Russia, Tunisia, Morocco and Algeria.

JHNH is owned by the JianHua Group and is the leading PVP manufacturer in China with an annual production of 5,000 metric tons from a plant in Quzhou.

The company meets all international standards for quality and safety including cGMP, ISO 9001 and ISO 14001 certifications. Its pharmaceutical products are marketed under the Povidone trade name from a newly established office in Shanghai and conform to USP/EP/JP with drug master files available.

The Povidone pharmaceutical range is suitable for a wide variety of applications including binders and stabilisiers for tablets, film formers and solubilisers for injection preparations, and disintegrants for tables, capsules and granules. To support their introduction, Azelis plans to provide prototype formulations and laboratory support, inviting customers for product training days and lab visits.

The two companies have a shared vision to drive market expansion and sustainable business development by providing high quality products, backed by good after sales care.

'Azelis is recognised for dedicated sales, marketing, technical support and supply chain excellence in the pharmaceutical industry,' said Tan Tiow Lin, General Manager, Global Sales and Marketing JHNH.

'At JHNH, we look forward to working with the Azelis pharma team to provide in-depth application insight to customers, helping to improve product performance and optimise cost-effectiveness.'

Matthew Dickman, International Business Director, Azelis Pharma, added: 'I am certain that this agreement will strengthen both our businesses across Europe, Russia, Turkey and North Africa, while at the same time giving our customers access to all that this key Chinese manufacturer can offer.'

  • Companies:
  • Azelis Group NV
See more

You may also like

Distribution

Azelis and Medichem extend partnership to DACH for the pharmaceutical, personal and home care markets

Read more
Azelis, a leading global innovation service provider in the specialty chemicals and food ingredients industry, is pleased to announce a new distribution agreement with Medichem, a developer and manufacturer of active pharmaceutical ingredients (APIs) and final dosage forms (FDFs)

Trending Articles

  1. CordenPharma & GENEPEP collaborate to leverage peptide drug substance discovery The partnership has facilitated the expedition of the development, discovery and manufacturing of peptides for early clinical phase
  2. Causes and solutions for dark spots in tablet manufacturing Natoli Engineering examines the causes and solutions for dark spots that can halt production
  3. The evolution of the pharma industry: From reactive to disruptive Globally, the pharma industry has witnessed waves of changes during the last century; we have evolved, writes Ajit Kanetkar, Head, Process Technology, ACG, from maintaining a conservative outlook and being solely reactive to disease and healthcare issues to having a radical and disruptive approach
  4. Highly potent APIs: Hazards in classification and handling This variability and subjective nature of classification means that the OEL is best considered as a tool for site risk management teams
  5. Small molecules: big market opportunities The rapid rise of biologic drugs in recent years has been accompanied by a market narrative that suggests that innovation and new treatments will be fuelled by breakthroughs in this area, leading to a decline in the small molecule pipeline. This is far from true, notes Kevin Cook, Chief Executive Officer at Sterling Pharma Solutions; both are increasing and small molecule drugs continue to be a mainstay of many drug development portfolios

Upcoming event

Making Pharmaceuticals

23–24 April 2024 | Exhibition | Coventry, UK See all

You may also like

Distribution

Azelis and Medichem extend partnership to DACH for the pharmaceutical, personal and home care markets

Azelis, a leading global innovation service provider in the specialty chemicals and food ingredients industry, is pleased to announce a new distribution agreement with Medichem, a developer and manufacturer of active pharmaceutical ingredients (APIs) and final dosage forms (FDFs)
Ingredients

Azelis completes Megafarma acquisition in Mexico

Megafarma is a premier speciality chemicals and food ingredient distributor
Ingredients

Azelis to enter Latin America with the acquisition of Megafarma

The transaction is expected to be completed within the next month
Ingredients

Azelis to acquire Turkish specialty chemicals distributor Ekin Kimya

The Istanbul-based company supplies chemicals for pharma, food ingredients and laboratory applications
Ingredients

Azelis gains a leading position in Australia and NZ with acquisition of Chemcolour

Azelis has agreed to fully acquire Chemcolour, a leading provider of specialty chemicals and food ingredients in Australia and New Zealand (ANZ)
Ingredients

Global cerium market estimated to grow strongly by 2021

Caprylic acid is used as raw material in manufacturing of surfactants, disinfectants, as an oil base and as emulsifiers in emulsion polymerisation.
Ingredients

New brand positioning for Azelis

Following its transformation into a global distributor of speciality chemicals and ingredients
Subscribe now